Purpose: To report a family affected by familial exudative vitreoretinopathy (FEVR) in which more severe disease phenotypes segregated with digenic rather than monogenic variants in FEVR-related genes. Methods: Phenotype was documented with high-resolution imaging of retinal structure and wide-field fundus photography. Next-generation sequencing (NGS) of known genes involved in FEVR was performed. Results: Three affected individuals within a family with FEVR presented with variable disease severity. All three affected family members harboured mutation c.349T>C (p.Cys117Arg) in FZD4. In addition, the youngest family member, a 9-year-old boy, who presented with bilateral tractional retinal detachment, and his mother, who presented with retinal pigmentary alterations and bilateral dragging of the macula and atrophy, both harboured the variant c.565T>C (p.Cys189Arg) in TSPAN12. Both suffered from bilateral severe visual loss. On the other hand, the older sister who presented with mild visual loss, temporal avascularity in the right eye and dragging of the blood vessels over the disc and macula in the left eye did not harbour the variant p.Cys189Arg in TSPAN12. Conclusion: These data suggest variants in more than one FEVR-related gene can underlie variable expressivity for FEVR phenotypes in a single family. Further studies of phenotype-genotype correlation, including next-generation sequencing, in larger cohorts of patients with FEVR are needed to investigate whether changes in more than one gene coding for proteins in the Norrin-bcatenin pathway are a recurrent cause for variable expressivity in the disease.
Introduction
Familial exudative vitreoretinopathy (FEVR) results from maldevelopment of the retinal vasculature, leading to peripheral retinal ischaemia which may lead to secondary neovascularization, exudation, dragging of the retina with radial folds, vitreous haemorrhage and tractional detachment (Criswick & Schepens 1969) . Age of onset is variable and a wide phenotype variability has been described, even in members of the same family with the same causative mutation (van Nouhuys 1991) .
Autosomal dominant (MIM 133780), recessive (MIM 601813) and X-linked (MIM 305390) modes of inheritance have been described. Causative genes encode ligands and receptors and coreceptors of the Norrin/b-catenin pathway and transcription factors with a role in vascular development. Norrin is derived from the retinal Muller cells, acting as a ligand that binds to receptors on the developing retinal endothelial cells. This leads to activation of intracellular b-catenin which is a transcription factor and an essential effector in this pathway. The specific target genes in the eye for b-catenin are not known. However, such genes have been studied in other organ systems where b-catenin is activated through Wnt signalling, which is a group of signal transduction pathways made of proteins that pass signals into cells through cell surface receptors, and for which Norrin is considered to be an agonist. Several such target genes have been identified (summarized in http://web.stanford.edu/ group/nusselab/cgi-bin/wnt/target_genes accessed on 9 December 2016) including those that may be expected to be involved in organ vascular development, such as vascular endothelial growth factor, matrix metalloproteinase-2 and matrix metalloproteinase-9 (Zhang et al. 2001; Wu et al. 2007 ).
FZD4 encodes a transmembrane G-coupled receptor protein belonging to the Wnt ligand-binding Frizzled family, which has been identified as the surface receptor for Norrin on the cell surface of the endothelial cells (Ye et al. 2009) , and has been associated with autosomal dominant and recessive FEVR. TSPAN12 encodes a member of the tetraspanin superfamily. It associates with the Norrin receptor complex and increases Norrin/b-catenin signalling. Signalling defects due to Norrin or FZD4 mutations that were predicted to impair receptor multimerization were rescued by overexpression of TSPAN12 (Junge et al. 2009 ). Thus, TSPAN12 co-operates with Norrin multimers to promote multimerization of FZD4 and its associated proteins, resulting in b-catenin signalling. Heterozygous but also homozygous and compound heterozygous mutations in TSPAN12 have been reported to cause FEVR (Nikopoulos et al. 2010; Poulter et al. 2012 ). FZD4 forms a transmembrane receptor complex with binding partners low-density lipoprotein receptor 5 (LRP5) and tetraspanin-12 (TSPAN12) (Bhanot et al. 1996) . Based on the postulated function of the proteins in the Norrinb-catenin pathway and their association with FEVR, it seems likely that FZD4, LRP5 and TSPAN12 interact to produce optimal Norrin/b-catenin signalling.
The cause of the observed phenotype variability in FEVR is unknown, and herein, we report a family in which affected members harboured heterozygous variants in one or in two genes associated with FEVR.
Materials and Methods
This retrospective study included three affected family members of Moroccan descent (mother age 42, daughter age 14 and son age 9) diagnosed with FEVR and the Saudi Arabian father (Fig. 1) . There was no history of consanguinity. IRB approval was obtained at King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. Informed consent was obtained.
Molecular genetic analysis by nextgeneration sequencing (NGS, Center for Human Genetics Bioscientia, Ingelheim, Germany) of known genes involved in FEVR (FZD4, LRP5, NDP, TSPAN12 and ZNF408) was performed as follows. Genomic DNA was fragmented, and the coding exons of the analysed genes as well as the corresponding exon-intron boundaries were enriched using the Roche/NimbleGen sequence capture approach, amplified and sequenced simultaneously by Illumina technology (NGS) using an Illumina HiSeq 1500 system (Illumina Inc., San Diego, CA, USA). For more than 98% of the regions of interest, a 20-fold coverage was obtained. NGS data analysis was performed using bioinformatic analysis tools as well as JSI MEDICAL SYSTEMS software (version 4.1.2, JSI Medical Systems GmbH, Ettenheim, Germany). Putatively pathogenic differences between the wildtype sequence (human reference genome according to UCSC Genome Browser: hg19, GRCh37) and the patients sequences were validated using polymerase chain reaction (PCR) amplification followed by conventional Sanger sequencing. The resulting sequence data for the FZD4 gene (OMIM: #604579; locus: chromosome 11q14.2) were compared to the reference sequence NM_012193.3, for the TSPAN12 gene (OMIM: #613138; locus: chromosome 7q31.31) to the reference sequence NM_012338.3. Karyotyping to exclude chromosomal aberrations was not performed; however, high coverage of NGS data enables copy number variation (CNV) analysis indicating deletions or duplications in the analysed genomic regions, which was not indicated.
Family members were examined clinically and with spectral-domain optical coherence tomography (SD-OCT) (Heidelberg Engineering, Inc., Heidelberg, Germany) and wide-field fundus photography (Optos PLC, Dunfermline, UK).
Results
Next-generation sequencing revealed the heterozygous missense variant c.349T>C in exon 2 of the FZD4 gene, which leads to the exchange of an evolutionarily conserved amino acid (p.Cys117Arg), in all three affected individuals. It is located in the extracellular Wnt-binding domain. In the wildtype protein, Cys117 forms a disulphide bond with Cys158 (in the cysteine-rich domain of FZD4) (Smallwood et al. 2007 ). Presumably, disruption of this bond causes a change in the FZD4 conformation, therefore affecting its ability to bind ligands. It has been described previously in two patients with autosomal dominant FEVR (Drenser et al. 2009 ). The mutation appears only once in the ExAc browser (Exome Aggregation Consortium, http://exac.broadinstitute.org/ accessed on 16 December 2015).
In addition, the heterozygous novel variant c.565T>C (p.Cys189Arg) in TSPAN12 was identified in two of the three affected family members (Fig. 1) . It is not reported in the ExAc browser nor in Single Nucleotide Polymorphism Database (dbSNP, accessed on 16 December 2015). This change affects the cysteine residue p.Cys189 next to the published mutation p.Gly188Arg (Poulter et al. 2012 ). This region is within the second extracellular loop of TSPAN12 which includes six cysteine residues forming disulphide bonds (Poulter et al. 2012) . Thus, each of the two missense variants in FZD4 and TSPAN12 could be causative for FEVR. No other variants were detected.
The affected 42-year-old mother harboured both the mutation p.Cys117Arg in FZD4 and the variant p.Cys189Arg in TSPAN12. She presented with a history of bilateral cataract surgery. Trabeculectomy was performed in the right eye 10 years prior to presentation, because of chronic angle closure. She had a history of possible retinal barrage laser performed many years ago. There was bilateral extensive and widespread pigmentary changes and dragging of the disc and vasculature and foveal ectopia (Fig. 2 top row) . Optical coherence tomography (OCT) showed absence of foveal pit and retinal thinning (Fig. 2 , bottom row). Visual acuity (VA) was hand motions in both eyes.
The affected 14-year-old daughter harboured the mutation p.Cys117Arg in FZD4, but not the variant p.Cys189Arg in TSPAN12. The right eye showed mild temporal avascularity whereas in the left eye, there was dragging of the vasculature over the disc and more pronounced temporal avascularity with peripheral exudates (Fig. 3, top row) . Optical coherence tomography (OCT) showed a normal fovea right eye and mild cystic changes in the left eye (Fig. 3, middle row) . Fluorescein angiography of the right eye showed mild peripheral temporal avascularity (Fig. 3, bottom right) . The left eye showed dragging of the vessels towards a peripheral fibrovascular mass with hyperfluorescence in an early frame (Fig. 3 , bottom middle) and late leakage (Fig. 3 bottom right) . Visual acuity (VA) was 20/25 in the right eye and 20/60 in the left eye.
The affected 9-year-old son harboured both the mutation p.Cys117Arg in FZD4 and the variant p.Cys189Arg in TSPAN12. His right eye showed severe exudation and subtotal retinal detachment with attached retina remaining in the superior area (Fig. 4,  top right) . In the left eye, there was a total retinal detachment (Fig. 4, top  left) . Optical coherence tomography (OCT) of the right eye showed tractional detachment involving the fovea and intraretinal exudates (Fig. 4, bottom) . Optical coherence tomography (OCT) of the left eye could not be reliably obtained due to bilateral sensory nystagmus. Visual acuity (VA) was 20/300 in the right eye and no light perception in the left eye. Fig. 3 . Fundus appearance, spectral-domain optical coherence tomography (SD-OCT) and fundus fluorescein angiography in an affected family member with familial exudative vitreoretinopathy. The affected 14-year-old daughter who harboured the heterozygous mutation p.Cys117Arg in FZD4, but not the variant p.Cys189Arg in TSPAN12. Top row: The right eye shows only mild temporal avascularity whereas in the left eye, there is some dragging of the vasculature over the disc and more pronounced temporal avascularity with peripheral exudates. Middle row: optical coherence tomography shows a normal fovea in the right eye and mild cystic changes in the left eye. Bottom row: Fluorescein angiography of the right eye shows mild peripheral temporal avascularity (bottom right). The left eye shows dragging of the vessels towards a peripheral fibrovascular mass with hyperfluorescence in an early frame (bottom middle) and leakage in a late frame (bottom right). In addition, there is a hyperpigmented scar temporal to the disc.
Discussion
The novel variant p.Cys189Arg in TSPAN12 was not identified in the affected 14-year-old daughter. Thus, we conclude that the heterozygous FZD4 missense variant c.349T>C most likely represents a causative dominant mutation in this family with FEVR.
We note that the above-mentioned 14-year-old daughter with the absence of this novel variant in TSPAN12 presented with a less severe phenotype, with milder changes of the retinal vascular anatomy and much better preserved visual acuity than her two fellow affected family members, leading to the hypothesis that this variant may modulate the phenotype in FZD4-associated FEVR. However, given the variably progressive nature of FEVR and considering the age of the patient, the long-term prognosis may be guarded. Progression of FEVR is not common in adults but has been described (Benson 1995) .
A potential interaction between mutations in two separate causative genes in FEVR has been suggested previously in the literature. In another study, the mutation c.1330C>T [p.Arg444Cys] in LRP5 was found in a family in which c.1250G>A [p.Arg417Gln] in FZD4 had previously been identified (Kondo et al. 2003; Qin et al. 2005) . The two mutations co-segregated within the family, indicating that both mutations are located on the same chromosome (Qin et al. 2005) . The phenotypes of three of four affected family members was said to be more severe than those of another family carrying the same FZD4 mutation only, suggesting a synergistic effect of the two mutations in the independent FEVR-causing genes (Qin et al. 2005) . A fundus photograph of the affected proband had been published previously; however, not much detail was provided regarding the fundus findings in the other family members (Kondo et al. 2003) . Salvo et al. (2015) performed NGS in a cohort of 92 patients with FEVR and described the identification of two probands that carried mutations in two genes associated with FEVR (FZD4/ LRP5 and TSPAN12/LRP5, respectively); however, no phenotype details were provided. Thus, based on that study, possibly digenic FEVR may be found in around 2% of the cases. Additionally, two brothers with FEVR featuring peripheral ridge (isolated finding in one of the brothers) and leukocoria with vitreoretinal fibrosis were found to have a frame shift mutation in FZD4 and a simultaneous missense mutation in LRP5 (Stiegel et al. 2013) . Finally, one patient with FEVR presenting with total tractional retinal detachment being initially misdiagnosed as persistent fetal vasculature was found to have compound heterozygous missense mutations in LRP5 and a simultaneous missense mutation in TSPAN12 (Kramer et al. 2016) .
In none of the above studies was there enough genotype/phenotype detail to enable definitive conclusions regarding genotype-phenotype correlations. This report thus adds to the complexity of FEVR associated with mutations in two potentially causative genes.
Our findings however do not explain the interocular asymmetry that may be observed in FEVR and that was seen for example in the 14-year-old daughter in this study (Fig. 3) . One can only speculate that there may be interocular differences in gene expression of the involved genes thus leading to a different mutational load between the two eyes. Phenotypic diversity in FEVR is well known. However, except for Salvo et al. 2015 , previous studies were not based on sequencing in all genes associated with FEVR, and some of these have been shown to cause FEVR only recently. Thus, one cannot exclude that some of the phenotypic diversity may have been caused by the concurrence of mutations in more than one FEVR-related gene. Fig. 4 . Fundus appearance and spectral-domain optical coherence tomography (SD-OCT) in an affected family member with familial exudative vitreoretinopathy. The affected 9-year-old son who harboured both the heterozygous mutation p.Cys117Arg in FZD4 and the variant p.Cys189Arg in TSPAN12. Top row: Right eye shows severe exudation and subtotal retinal detachment with attached retina remaining in the superior area. In the left eye, there is a total retinal detachment. Bottom row: optical coherence tomography of the right eye showing tractional detachment involving the fovea and intraretinal exudates. Optical coherence tomography (OCT) of the left eye could not be reliably obtained due to nystagmus, which also explains the blurred fundus photographs and the poor quality of the optical coherence tomography scan of the right eye.
On the other hand, we cannot exclude the possibility of a novel gene involvement in the present study, as whole exome was not analysed.
In summary our report adds to the complexity of FEVR genotypes and illustrates a situation where phenotype variability may be influenced by variants in more than one gene affecting the Norrin-b-catenin. Sequencing all FEVR-associated genes may be helpful in explaining the severe phenotypes observed in some of the patients. Further study is warranted including larger cohorts of patients with FEVR.
